Product Information

DARIFENACIN ER 7.5 MG TABLET is a generic product labeled by Macleods Pharmaceuticals Limited, priced at $0.6029 per EA under NDC 33342027610. Its NADAC has been published 377 times since Mar 14, 2018.

The High Outlier badge above means this manufacturer's average price in the Darifenacin market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.

DARIFENACIN ER 7.5 MG TABLET

Darifenacin
$0.6029per EA
High Outlier

Strength

7.5 mg/1

NDC

33342027610

Classification

Generic

Dosage Form

TABLET, EXTENDED RELEASE

Route

ORAL

Last Updated

5/21/2025

Active Ingredients

DARIFENACIN HYDROBROMIDE

Approval Type

Generic (ANDA)

FDA Application

ANDA207302

On Market Since

7/29/2017

Pharmacological Classes

Cholinergic Muscarinic Antagonist
Cholinergic Muscarinic Antagonists

Price Statistics

The NADAC for DARIFENACIN ER 7.5 MG TABLET has been published 377 times since Mar 14, 2018, and over the history we have for it it has declined 90.3%. The table below summarizes its recorded NADAC range and movement.

Current price$0.6029 per EA
All-time high$6.2042 (Mar 14, 2018)
All-time low$0.5516 (Nov 20, 2024)
Median price$1.8326
Average price$2.2026
Largest weekly change+76.3% (May 22, 2019)
Weeks tracked377
Tracking sinceMar 14, 2018

Price History

1W

0.0%

1M

0.0%

3M

0.0%

6M

0.0%

1Y

0.0%

3Y

-34.9%

5Y

-67.5%

All

-90.3%

Generic Alternatives

The matcher finds 4 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 4 manufacturers (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 15% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of DARIFENACIN ER 7.5 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for DARIFENACIN ER 7.5 MG TABLET, manufactured by Macleods Pharmaceuticals Limited, is $0.6029 per EA (NDC 33342027610), effective May 28, 2025.

How has the price of DARIFENACIN ER 7.5 MG TABLET changed over time?

Over the history we have for it, the NADAC for DARIFENACIN ER 7.5 MG TABLET has declined 90.3%. It has been tracked across 377 weekly CMS publications since Mar 14, 2018.

What are the highest and lowest recorded NADAC prices for DARIFENACIN ER 7.5 MG TABLET?

Since Mar 14, 2018, the NADAC for DARIFENACIN ER 7.5 MG TABLET has ranged from a low of $0.5516 (Nov 20, 2024) to a high of $6.2042 (Mar 14, 2018), with a median of $1.8326 per EA.

Are there cheaper alternatives to DARIFENACIN ER 7.5 MG TABLET?

Yes. 4 NADAC-published products share the same active ingredient, strength, and dosage form. The lowest-priced option, DARIFENACIN ER 7.5 MG TABLET, is $0.5115 per EA — about 15% below DARIFENACIN ER 7.5 MG TABLET.

Who manufactures DARIFENACIN ER 7.5 MG TABLET?

DARIFENACIN ER 7.5 MG TABLET (NDC 33342027610) is labeled by Macleods Pharmaceuticals Limited, and CMS classifies it as a generic product.